Publications by authors named "Irene Silva Torres"
Article Synopsis
- Diabetes can be a risk factor for cancer, but there is limited research on how post-transplant diabetes mellitus (PTDM) influences cancer risk after organ transplants.
- In a study of Spanish patients without diabetes before transplant, researchers found that PTDM did not generally increase cancer risk, but indicated a significant association with renal cell cancer (RCC).
- The study suggests that patients with PTDM should be monitored closely for RCC due to their higher risk compared to those without PTDM.
Prediabetes and post-transplant diabetes mellitus affect about 20-30% of renal transplant patients. The latter is a risk factor for cardiovascular disease. However, no clear evidence linking prediabetes and cardiovascular disease is available.
View Article and Find Full Text PDFClinical evolution of post-transplant diabetes mellitus.
Esteban L Porrini Jose M Díaz Francisco Moreso Patricia I Delgado Mallén Irene Silva Torres Armando Torres
Nephrol Dial Transplant
March 2016
Background: The long-term clinical evolution of prediabetes and post-transplant diabetes mellitus (PTDM) is unknown.
Methods: We analysed, in this cohort study, the reversibility, stability and progression of PTDM and prediabetes in 672 patients using repeated oral glucose tolerance tests (OGTTs) for ≤5 years.
Results: Most patients were on tacrolimus, steroids and mycophenolate.